A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

ClinicalTrials.gov ID: NCT07430306

Public ClinicalTrials.gov record NCT07430306. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 6, 2026, 8:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multinational, Interventional, 52-week, Open-label, Single-arm Study to Evaluate the Treatment Outcomes of Anifrolumab 120 mg Subcutaneous Once Weekly in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus (SUNFLOWER)

Study identification

NCT ID: NCT07430306
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: AstraZeneca; Industry
Enrollment: 245 participants

Conditions and interventions

Conditions

Systemic Lupus Erythematosus

Interventions

Anifrolumab Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 70 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Apr 12, 2026
Primary completion: Jan 25, 2029
Completion: Jan 25, 2029
Last update posted: May 4, 2026

2026 – 2029

United States locations

U.S. sites: 21
U.S. states: 11
U.S. cities: 19

Facility	City	State	ZIP	Site status
Research Site	Anniston	Alabama	36207	Withdrawn
Research Site	Phoenix	Arizona	85032	Not yet recruiting
Research Site	Fontana	California	92335	Not yet recruiting
Research Site	La Palma	California	90623	Not yet recruiting
Research Site	Menifee	California	92586	Recruiting
Research Site	San Leandro	California	94578	Not yet recruiting
Research Site	Temecula	California	92592	Recruiting
Research Site	Miami	Florida	33145	Not yet recruiting
Research Site	Miami	Florida	33180	Suspended
Research Site	Willowbrook	Illinois	60527	Not yet recruiting
Research Site	New Albany	Indiana	47150	Not yet recruiting
Research Site	Kansas City	Missouri	64151	Not yet recruiting
Research Site	Oklahoma City	Oklahoma	73116	Recruiting
Research Site	Memphis	Tennessee	38104	Not yet recruiting
Research Site	Memphis	Tennessee	38119	Recruiting
Research Site	Austin	Texas	78745	Not yet recruiting
Research Site	Baytown	Texas	77521	Not yet recruiting
Research Site	Colleyville	Texas	76034	Not yet recruiting
Research Site	Edinburg	Texas	78550	Not yet recruiting
Research Site	Houston	Texas	77054	Not yet recruiting
Research Site	Spokane	Washington	99204	Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 51 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07430306, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 4, 2026 · Synced May 6, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07430306 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →